Merck & Co. to Acquire SmartCells and its Glucose-Responsive Insulin Technology
By Heather Cartwright
Pharma Deals Review: Vol 2010 Issue 10 (Table of Contents)
Published: 22 Dec-2010
DOI: 10.3833/pdr.v2010.i10.1413 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
SmartCells, a privately held insulin developer, has received a buyout offer from Merck & Co...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS